---
date: "2021-04-10T00:00:00Z"
external_link: ""
image:
  focal_point: Smart
  preview_only: true
summary: Two-stage open-label, single arm phase I/IIa trial of carbamazepine in children with skeletal dysplasia
tags:
- MCDS
- Ongoing-trial
title: MCDS
url_code: ""
url_pdf: ""
url_slides: ""
url_video: ""
---

MCDS is funded by a [Horizon 2020](https://ec.europa.eu/programmes/horizon2020/en/home) grant to CI [Michael Wright](https://newcastle.mic.nihr.ac.uk/staff/dr-michael-wright/) and team.

It is testing whether carbamazepine can reduce the pain and mobility difficulties MCDS patients face.

You can find out more from MCDS's [website](https://mcds-therapy.eu/), or from it's registration on [ISCRTN](https://doi.org/10.1186/ISRCTN37815869),.
